Colon Cancer

Strategy tied to better outcomes but fails to meet primary goal of phase II trial

Also in TTHealthWatch: CVD death and obesity

But researchers say the established benefits likely outweigh any potential risk

Meta-analysis turns up similar findings, though increased ADR overall

A series of articles look at whether the benefits for the few warrant the harms for the many

Studies show their potential, but reveal clear issues with treatment information reliability

More than half of patients with NSCLC, more than a third of those with CRC responded to divarasib

Experts will discuss the chemotherapy drug shortages and the impact on patients

News, features, and commentary about cancer-related issues

Guidance conflicts with other new recommendations that screening start at age 45

These tests could soon become a valuable addition to current cancer screening tools

OS rates could be over 80% depending on clinical predictive factors

More than 70% of patients with a median age of 79 achieved both outcomes at 3-6 months

Higher cardiorespiratory fitness linked to lower risk of death from colon, lung, prostate cancers